Effects of Mdm2 Inhibitors on Cellular Viability of Breast Cancer Cell Lines HP100, MCF7
Bratislava Medical Journal · 2024 · 125 (10) · 627-634
DOI: 10.4149/bll_2024_97 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bratislava Medical Journal, 2024. Verfasst von Hany Akeel Al-Hussaniy und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Doxorubicin, Breast Neoplasms, Imidazoles. Die Arbeit wurde bisher 26-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Al-Hussaniy, H. A., & J Al-Zobaidy, M. (2024). Effects of Mdm2 Inhibitors on Cellular Viability of Breast Cancer Cell Lines HP100, MCF7. Bratislava Medical Journal, 125(10), 627-634. https://doi.org/10.4149/bll_2024_97
Vancouver
Al-Hussaniy HA, J Al-Zobaidy M. Effects of Mdm2 Inhibitors on Cellular Viability of Breast Cancer Cell Lines HP100, MCF7. Bratislava Medical Journal. 2024;125(10):627-634. doi:10.4149/bll_2024_97
BibTeX
@article{AlHussaniy2024,
author = {Al-Hussaniy, Hany Akeel and J Al-Zobaidy, Mohammed},
title = {Effects of Mdm2 Inhibitors on Cellular Viability of Breast Cancer Cell Lines HP100, MCF7},
journal = {Bratislava Medical Journal},
year = {2024},
volume = {125},
number = {10},
pages = {627--634},
doi = {10.4149/bll_2024_97}
}
EUVIMED